AI, Cancer, and HIV An interview with Dr. Olivier Elemento

June 10, 2025

Olivier Elemento, PhD, is Director of the Englander Institute for Precision Medicine and Associate Director of the Institute for Computational Biomedicine at Weill Cornell Medicine. His research group combines big data and artificial intelligence with experimentation and genomic profiling to accelerate the discovery of cancer cures. amfAR VP and Director of Research Andrea Gramatica, PhD, spoke with Dr. Elemento about his work and its potential applications in HIV research....

EIPM Scientific Director Massimo Cristofanilli M.D.

Treatment switch, liquid biopsy improve breast cancer outcomes

June 10, 2025

A large prospective randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistant mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

The SERENA-6 study, published June 1 in the New England Journal of Medicine and presented concurrently at...

June 2025 EIPM Director's Memo

June 10, 2025

June 2025 EIPM Director's Memo

Dear Friends & Members of the Englander Institute,

I hope you enjoy reading about our recent departmental accomplishments, including news media coverage of our work, participation in major conferences & meetings, and impressive publications in top-tier journals like The New England Journal of Medicine, Nature Communications, and Science Signalingby a range of EIPM colleagues.

Thank you again...